CDH1 promoter hypermethylation has been found in 54.8% of analyzed cases of sporadic gastric cancer (42) and in 28.6 of cases, the downregulation of E-cadherin may be associated with a poor prognosis [Graziano et al (43)]. This evidence concerns the gene CDH1 and gastric cancer.